🇺🇸 FDA
Patent

US 11000588

Etanercept formulations stabilized with sodium chloride

granted A61KA61K38/1793A61K39/39591

Quick answer

US patent 11000588 (Etanercept formulations stabilized with sodium chloride) held by Coherus BioSciences, Inc. expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Coherus BioSciences, Inc.
Grant date
Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/1793, A61K39/39591